Cargando…

How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study

BACKGROUND: Previous infections and vaccinations have produced preexisting immunity, which differs from primary infection in the organism immune response and may lead to different disease severities and prognoses when reinfected. OBJECTIVES: The purpose of this retrospective cohort study was to inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yiting, Zhao, Bennan, Zhang, Xinyi, Zhang, Xia, Gao, Fengjiao, Yuan, Xiaoyan, Ren, Xiaoxia, Li, Maoquan, Liu, Dafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627193/ https://www.ncbi.nlm.nih.gov/pubmed/37936709 http://dx.doi.org/10.3389/fimmu.2023.1246751

Ejemplares similares

High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients
por: Liu, Dafeng, et al.
Publicado: (2022)

Nutritional risk and a high NRS2002 score are closely related to disease progression and poor prognosis in patients with COVID-19
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus
por: Liu, Dafeng, et al.
Publicado: (2020)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Breakthrough of glycobiology in the 21st century
por: Mahara, Gehendra, et al.
Publicado: (2023)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
por: Ahmed, Mohamed Ibraheem Mahmoud, et al.
Publicado: (2022)

Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus
por: Liu, Dafeng, et al.
Publicado: (2021)

Can CD200R1 Agonists Slow the Progression of Osteoarthritis Secondary to Injury?
por: Vachhani, Kathak, et al.
Publicado: (2022)

The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
por: Gao, Feng, et al.
Publicado: (2022)

A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma
por: Zhang, Xiaoyan, et al.
Publicado: (2023)

A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2019)

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
por: Johnson, Sara D., et al.
Publicado: (2016)

Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years
por: Liu, Dafeng, et al.
Publicado: (2021)

Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children
por: Roider, Julia, et al.
Publicado: (2019)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
por: Jonny, Jonny, et al.
Publicado: (2022)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
por: Chang, Lauren A., et al.
Publicado: (2023)

Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
por: Shao, Shengwen, et al.
Publicado: (2023)

Ironing Out the Details: How Iron Orchestrates Macrophage Polarization
por: Xia, Yaoyao, et al.
Publicado: (2021)

Oocytes could rearrange immunoglobulin production to survive over adverse environmental stimuli
por: Wang, Yang, et al.
Publicado: (2022)

A Potential Bioelectromagnetic Method to Slow Down the Progression and Prevent the Development of Ultimate Pulmonary Fibrosis by COVID-19
por: Masaud, Syed Muzzammil, et al.
Publicado: (2020)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
por: He, Xiaomeng, et al.
Publicado: (2023)

Pandemics: Historically Slow “Learning Curve” Leading to Biomedical Informatics and Vaccine Breakthroughs
por: Kulikowski, Casimir A.
Publicado: (2021)

Corrigendum: A potential bioelectromagnetic method to slow down the progression and prevent the development of ultimate pulmonary fibrosis by COVID-19
por: Masaud, Syed Muzzammil, et al.
Publicado: (2022)

Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
por: Zou, Qian, et al.
Publicado: (2022)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Dendritic cell activation and cytokine response in vaccine breakthrough TBE patients after in vitro stimulation with TBEV
por: Marušić, Miša, et al.
Publicado: (2023)

Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
por: Flynn, Jacqueline K., et al.
Publicado: (2019)

Effect of D-Ala-Ended Peptidoglycan Precursors on the Immune Regulation of Lactobacillus plantarum Strains
por: Song, Xin, et al.
Publicado: (2022)

Two Cases of COVID-19 with Persistently Positive SARS-CoV-2-Specific IgM During One-Year Follow-Up — Sichuan Province, China, February 2021
por: Zhao, Bennan, et al.
Publicado: (2021)

Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination
por: Chen, Zhongbao, et al.
Publicado: (2023)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury
por: Zhao, Shuang, et al.
Publicado: (2022)

NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Zhong, Chaoqin, et al.
Publicado: (2021)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
por: Lee, Chan Mi, et al.
Publicado: (2023)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lucpteci6u8s22398246gc4v95